Trials / Completed
CompletedNCT02971215
Subacromial Impingement Syndrome Approach Using High Intensity Laser Therapy
Effectiveness of High Intensity Laser Therapy in the Treatment of Subacromial Impingement Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- University of Castilla-La Mancha · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effectiveness of high intensity laser therapy in the treatment of subacromial impingement syndrome.
Detailed description
Shoulder pain has a high prevalence in our society, several studies estimate an annual prevalence between 5% and 47%. It is one of the main causes of musculoskeletal pain, particularly in third place, after the low back pain and neck pain. Symptoms of pathologies of subacromial space impingement syndrome, where, regardless of origin, pain is the number one symptom for the patient, which emanates functional impairment and the impact on quality of life. Because of the need to implement research to assess the effectiveness of high intensity laser therapy with new studies mayor methodological quality of obtaining conclusive results, and based on the scientific evidence supporting the low-power laser therapy as a useful tool in addressing the shoulder tendon pathology, we consider very interesting the realization of this research project.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iLux Laser | Treatment during 15 sessions. It is divided in two phases: 1. 12W. 50 Hz 20% duty cycle. 50 J/cm² in painful zone. 2. 15 W. Burst (10 pulses-900 msec each train) 250 J/cm² in painful zone. Trough the iLux Laser (Mectronic Medicale, Italy) \+ Physical Therapy protocol. |
| DEVICE | Sham ilux Laser | Sham treatment during 15 sessions trough the iLux Laser (Mectronic Medicale, Italy), It is applies the same time than experimental one but with 0 W + Physical Therapy protocol. |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2016-11-22
- Last updated
- 2017-11-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02971215. Inclusion in this directory is not an endorsement.